Senegals Political Turmoil Deepens as President Faye Sacks Prime Minister Dissolves Government Amid Debt Crisis Five Childrens Toys Sold in Britain Found to Contain Asbestos Guardian Investigation Reveals Bloom Energy Shares Surge on 26 Billion Data Center Deal with AI Cloud Provider Nebius Average Traders Outperform Wall Street on Prediction Markets NYT Reports Homeowners Insurance Strategies How Policyholders Could Reduce Premiums in 2025 Prediction Market Investments Persist Despite Regulatory Uncertainty Ivanhoe Electric Inc IE Q1 2026 Earnings EPS Miss Widens as Exploration Costs Weigh on Results CTXR Q4 2025 Earnings Missed Estimates Amid No Revenue Stock Rises SOWG Q3 2025 Earnings Significant EPS Miss Overshadows Quarter Mattel Q1 2026 Earnings NarrowerThanExpected Loss Amid Cost Discipline CNSP Q1 2026 Earnings WiderthanExpected Loss Highlights ClinicalStage Cash Burn My Size Inc MYSZ Q4 2025 Earnings EPS Falls Short of Expectations Amid Revenue Disclosures Vine Hill Capital Investment Corp VCIC Slides 65 as Selling Pressure Builds Key Support in Focus Immunome Inc IMNM Rises Nearly 2 as Support Holds Resistance in Sight EUDA Health Holdings EUDA Rallies 369 as Buyers Step In Near Support Cartesian Growth Corporation III Unit CGCTU Gains 46 as Unit Price Tests Key Resistance Zone Gesher Acquisition Corp II Warrants GSHRW Rallies 949 as Price Approaches Resistance at 025 APH Q1 2026 Earnings EPS Smashes Estimates Amid Strong Demand Shares Surge SREA Q1 2026 Earnings Earnings Per Share Slightly Misses Consensus Notes Edge Higher BLSH Q1 2026 Earnings EPS Misses Estimates Stock Declines 217 Borr Drilling BORR Q1 2026 Earnings WiderthanExpected Loss as Offshore Market Challenges Persist Personalis Inc PSNL Q1 2026 Earnings EPS Misses Estimates but Stock Jumps 6 on LongTerm Optimism RELX Q2 2025 Earnings Modest EPS Beat Amid Flat Revenue Disclosure Stock Declines White House Highlights Soybean and Rare Earth Deals After TrumpXi Summit as China Signals Potential Tariff Reductions CanFite Biopharma Q4 2023 Earnings Significant EPS Surprise as Biotech Focuses on Clinical Pipeline SHMDW Warrants Slip 86 as SCHMID Group Faces Renewed Selling Pressure